Stocks and Investing Stocks and Investing
Mon, August 28, 2023

Ryan Zimmerman Maintained (TMCI) at Strong Buy with Decreased Target to $28 on, Aug 28th, 2023


Published on 2024-10-28 06:09:19 - WOPRAI, Ryan Zimmerman
  Print publication without navigation


Ryan Zimmerman of BTIG, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Decreased Target from $32 to $28 on, Aug 28th, 2023.

Ryan has made no other calls on TMCI in the last 4 months.



There are 2 other peers that have a rating on TMCI. Out of the 2 peers that are also analyzing TMCI, 1 agrees with Ryan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • George Sellers of "Stephens & Co." Maintained at Hold with Decreased Target to $25 on, Thursday, August 10th, 2023


This is the rating of the analyst that currently disagrees with Ryan


  • Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $30 on, Wednesday, August 9th, 2023
Contributing Sources